Filter
2266
Filtered Results: 2266
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
255
New Publications
711
Language
Document type
No document type
1337
Guidelines
336
Studies & Reports
296
Manuals
130
Strategic & Response Plan
107
Training Material
26
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
3
Online Courses
1
Countries / Regions
India
158
Kenya
77
Global
70
South Africa
64
Nigeria
60
Uganda
55
Nepal
48
Tanzania
48
Sierra Leone
46
Western and Central Europe
44
Ghana
41
Zambia
39
Myanmar / Burma
37
Ethiopia
36
Malawi
35
Namibia
32
Bangladesh
31
Liberia
31
Africa
25
Lesotho
19
Eastern Europe
19
South–East Asia Region
18
Rwanda
16
Zimbabwe
16
Cambodia
15
Asia
14
Latin America and the Carribbean
14
Botswana
13
Ukraine
12
Syria
12
Philippines
12
Congo, Democratic Republic of
10
Indonesia
10
Russia
8
Tajikistan
7
Cameroon
7
South Sudan
7
Eswatini/ Swaziland
7
Albania
6
Senegal
6
West and Central Africa
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
East and Southern Africa
6
Pakistan
6
Thailand
5
Burkina Faso
5
Middle East and North Africa
5
Laos
4
Guinea
4
Mozambique
4
Afghanistan
3
Germany
3
Sri Lanka
3
Sudan
3
Georgia
3
Iraq
3
Benin
2
China
2
Kyrgyzstan
2
USA
2
Haiti
2
United Kingdom
2
Brazil
2
Bhutan
2
Somalia
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Iran
1
Canada
1
Singapore
1
Uzbekistan
1
Peru
1
Qatar
1
Bulgaria
1
Lithuania
1
Jordan
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Lebanon
1
Vietnam
1
Moldova
1
Yemen
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
932
Clinical Guidelines
229
Public Health
140
Key Resources
105
Women & Child Health
104
Pharmacy & Technologies
40
Capacity Building
36
Toolboxes
HIV
257
TB
193
AMR
148
Mental Health
132
COVID-19
76
Pharmacy
74
NTDs
74
Caregiver
53
Rapid Response
49
NCDs
44
Ebola & Marburg
38
Malaria
36
Planetary Health
33
Global Health Education
29
Conflict
28
Disability
24
Refugee
22
Health Financing Toolbox
11
Polio
11
Natural Hazards
10
Cholera
9
Specific Hazards
8
Zika
5
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been translated into firm commitments in February 2016, t...
The Global Reference List of 100 Core Health Indicators is a standard set of core indicators prioritized by the global community to provide concise information on the health situation and trends, including responses at national and global levels.
This second (2018) edition builds on the previous ...
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered of
special concern for possible use in terrorism. All of these
agents c...
2nd edition
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
Technical Series on Safer Primary Care
Water, sanitation and hygiene (WASH) are critical in the prevention and care for all of the 17 neglected tropical diseases (NTDs) scheduled for intensified control or elimination by 2020.
Provision of safe water, sanitation and hygiene is one of the five key interventions within the global NTD ...
Provision of safe water, sanitation and hygiene is one of the five key interventions within the global NTD ...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development ...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Lancet Infectious Diseases Volume 22, Issue 11e327-e335.
In February, 2022, WHO published new guidelines with six recommendations to update the global public health strategy against schistosomiasis, including expansion of preventive chemotherapy eligibility from the predominant group of school-age...
